Bayer stock: UBS keeps EUR 62.00 target for Bayer stock

Published on 10/20/2026 at 15:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Bayer is scheduled to report third-quarter results on November 3, 2026. Bayer stock costs EUR 43.44 on October 20, 2026, plus 0.09 percent versus the Xetra close.

Analyst target and reporting date

UBS kept its EUR 62.00 Bayer target in a report dated October 18, 2026.
Third-quarter consensus points to EUR 0.39 earnings per share versus a EUR 0.98 loss.
Bayer stock costs EUR 43.44 at Lang & Schwarz on October 20, 2026 at 3:40 p.m. CEST, 0.09 percent above the Xetra close of October 19, 2026, and 19.44 percent below the 52-week high.
Bayer is scheduled to publish third-quarter results on November 3, 2026.

Pop-Art-Comicpanel: begeisterter Forscher im weißen Kittel hält Reagenzglas triumphierend hoch, große Sprechblase mit DISCOVERY!, gelber Hintergrund mit roten Rasterpunkten, blauer Explosionsstern — Pop-Art-Comic im Lichtenstein-Stil: Forscher im Kittel hält jubilierend Reagenzglas hoch, Sprechblase DISCOVERY!, Illustration mit AI erstellt.

UBS kept its EUR 62.00 price target for Bayer on October 18, 2026, according to 4investors. The target is 42.87 percent above the EUR 43.44 Bayer stock price at Lang & Schwarz on October 20, 2026 at 3:40 p.m. CEST, which stood 0.09 percent above the Xetra close of October 19, 2026 at EUR 43.40.

Results date sets the next test

Bayer is scheduled to publish its third-quarter 2026 results on November 3, 2026. Stock-World reported that consensus estimates point to EUR 0.39 earnings per share for the quarter, compared with a EUR 0.98 loss in the prior-year quarter.

Stock stays below its yearly high

The Bayer quote is 19.44 percent below its 52-week high of EUR 53.92 and 68.51 percent above its 52-week low of EUR 25.78. Volume stood at 520,014 shares at 3:40 p.m. CEST on October 20, 2026, while Bayer's market capitalization was EUR 42.7 billion.

Valuation meets cautious estimates

The analyst case rests on a wide gap between the current quote and the UBS target, but the operating test remains the third-quarter release. The same consensus cited by Stock-World expects quarterly revenue of EUR 9.87 billion, up 2.19 percent from the prior-year quarter, while the earnings estimate implies a sharper change than sales.

Comparison with peers

Bayer: up 0.09 percent, market capitalization EUR 42.7 billion, DAX. BASF (Xetra, EUR): down 0.32 percent, market capitalization EUR 45.3 billion. Merck KGaA (Xetra, EUR): up 0.83 percent, market capitalization EUR 63.3 billion.

What the target means for Bayer

The target distance gives the stock a substantial valuation gap to close, while the upcoming report will test whether the expected earnings recovery is supported by operating performance. The current price remains below the yearly high and above the yearly low.

Bayer stock was trading at EUR 43.44 at Lang & Schwarz on October 20, 2026 at 3:40 p.m. CEST, 0.09 percent above the Xetra close of October 19, 2026 at EUR 43.40. The further course of trading is shown by the continuously updated real-time quote of Bayer stock.